Emzor Pharmaceutical Industries Limited
Нигерийский фармацевтический производитель Эмзолина, Эмтрикса и широкого ассортимента основных лекарств.
Emzor Pharmaceutical Industries Limited производит таблетки, сиропы, мази и инъекционные препараты для рынка здравоохранения Нигерии. Ее продукция включает сиропы от кашля, анальгетики, противомалярийные препараты и пищевые добавки.
- Type
- brand seeking distribution
- Location
- Isolo, Nigeria
- Founded
- 1984
- Website
- https://www.emzorpharma.com
- Categories
- БАДы и товары для здоровья, Медицинские товары и расходники
- Markets
- Нигерия, Гана, Кот-д’Ивуар
Verified facts
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- web-presence-since (green), checked 2026-08-02 Internet Archive (Wayback)
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)